Did revised federal standards make transplant centers more averse to risk and encourage them to drop sicker patients who might affect the hospitals' patient survival rates? ERproductions Ltd/Blend Images/Getty Images hide caption

toggle caption ERproductions Ltd/Blend Images/Getty Images

Dr. Dorry Segev (right), of Johns Hopkins Medicine, led the team of doctors that transplanted an HIV-positive liver and kidney into two different HIV-positive patients this month. Johns Hopkins Medicine hide caption

toggle caption Johns Hopkins Medicine

New Source Of Transplant Organs For Patients With HIV: Others With HIV

  • Download
  • <iframe src="https://www.npr.org/player/embed/472389956/472501076" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A 12-week regimen of Harvoni is 90 percent effective in curing an infection with hepatitis C, doctors say. It also costs about $95,000. Baltimore Sun/TNS via Getty Images hide caption

toggle caption Baltimore Sun/TNS via Getty Images

States Deny Pricey Hepatitis C Drugs To Most Medicaid Patients

  • Download
  • <iframe src="https://www.npr.org/player/embed/460086615/461206268" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Surgeons at Methodist University Hospital in Memphis prepare to transplant a liver in 2010. Karen Pulfer Focht/The Commercial Appeal/Landov hide caption

toggle caption Karen Pulfer Focht/The Commercial Appeal/Landov

Who Gets First Dibs On Transplanted Liver? Rules May Change

  • Download
  • <iframe src="https://www.npr.org/player/embed/339579923/340289327" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A Struggle To Define 'Death' For Organ Donors

  • Download
  • <iframe src="https://www.npr.org/player/embed/149463045/149512188" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">